Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02426892
Title Nivolumab and HPV-16 Vaccination in Patients With HPV-16 Positive Incurable Solid Tumors
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

cervical cancer

vaginal cancer

penile cancer

anal canal cancer

vulva cancer

oropharynx cancer

Therapies

Nivolumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.